![Zaozhuang, China. 01st Jan, 2022. (220101) -- ZAOZHUANG, Jan. 1, 2022 (Xinhua) -- Medical workers prepare to inject Spinraza to a 4-year-old child diagnosed with spinal muscular atrophy (SMA) at a hospital Zaozhuang, China. 01st Jan, 2022. (220101) -- ZAOZHUANG, Jan. 1, 2022 (Xinhua) -- Medical workers prepare to inject Spinraza to a 4-year-old child diagnosed with spinal muscular atrophy (SMA) at a hospital](https://c8.alamy.com/comp/2HCTTD3/zaozhuang-china-01st-jan-2022-220101-zaozhuang-jan-1-2022-xinhua-medical-workers-prepare-to-inject-spinraza-to-a-4-year-old-child-diagnosed-with-spinal-muscular-atrophy-sma-at-a-hospital-in-zaozhuang-east-chinas-shandong-province-jan-1-2022-china-is-striving-to-improve-the-diagnosis-and-treatment-of-rare-diseases-recently-a-tear-jerking-video-showing-how-a-national-health-insurance-negotiator-helped-cut-down-the-bidding-price-of-spinraza-from-over-53680-yuan-8422-us-dollars-per-dose-to-33000-yuan-went-viral-online-and-was-lauded-by-netizens-spinraza-a-medici-2HCTTD3.jpg)
Zaozhuang, China. 01st Jan, 2022. (220101) -- ZAOZHUANG, Jan. 1, 2022 (Xinhua) -- Medical workers prepare to inject Spinraza to a 4-year-old child diagnosed with spinal muscular atrophy (SMA) at a hospital
![Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy | Globalnews.ca Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy | Globalnews.ca](https://i1.wp.com/media.globalnews.ca/videostatic/819/355/2019-07-04T21-51-48.1Z--640x360.jpg?w=1040&quality=70&strip=all)
Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy | Globalnews.ca
![The New England Journal of Medicine Publishes SPINRAZA® (nusinersen) Phase 3 Study Results in Individuals with Later-Onset Spinal Muscular Atrophy | Biogen The New England Journal of Medicine Publishes SPINRAZA® (nusinersen) Phase 3 Study Results in Individuals with Later-Onset Spinal Muscular Atrophy | Biogen](https://investors.biogen.com/sites/g/files/knoqqb80686/themes/site/nir_pid1897/dist/images/banner1.jpg)
The New England Journal of Medicine Publishes SPINRAZA® (nusinersen) Phase 3 Study Results in Individuals with Later-Onset Spinal Muscular Atrophy | Biogen
![Stiže još bolji lijek za spinalnu mišićnu atrofiju od Spinraze, u EU i Hrvatskoj se očekuje iduće godine - Dnevno.hr Stiže još bolji lijek za spinalnu mišićnu atrofiju od Spinraze, u EU i Hrvatskoj se očekuje iduće godine - Dnevno.hr](https://www.dnevno.hr/wp-content/uploads/2020/08/nusinersen-spinraza.png)